Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,184 | -16,700 | -10,774 | -4,894 | -3,473 |
| Depreciation Amortization | 10 | 1 | 2 | N/A | N/A |
| Other Working Capital | 350 | -105 | -362 | -126 | -21 |
| Other Operating Activity | 7,762 | 14,312 | 4,841 | 72 | 166 |
| Operating Cash Flow | $-5,062 | $-2,491 | $-6,292 | $-4,948 | $-3,328 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -128 | -2 | -17 | -8 | -1 |
| Investing Cash Flow | $-128 | $-2 | $-17 | $-8 | $-1 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -103 | -63 | -140 | -140 | -103 |
| Common Stock Issued | 14,329 | 2,877 | 2,896 | N/A | 3,464 |
| Other Financing Activity | 102 | 24 | 3,467 | 3,467 | 0 |
| Financing Cash Flow | $14,328 | $2,837 | $6,224 | $3,327 | $3,361 |
| Beginning Cash Position | 5,533 | 5,533 | 5,619 | 5,619 | 5,619 |
| End Cash Position | 14,671 | 5,878 | 5,533 | 3,990 | 5,650 |
| Net Cash Flow | $9,137 | $344 | $-85 | $-1,629 | $32 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,062 | -2,491 | -6,292 | -4,948 | -3,328 |
| Capital Expenditure | -128 | -2 | -17 | -8 | -1 |
| Free Cash Flow | -5,191 | -2,493 | -6,309 | -4,956 | -3,329 |